Prolerity + Tandem
We’re excited to share Tandem Clinical Research is now part of Prolerity, and will continue to bring patient diversity and exceptional quality to clinical trials. Operating 11 research sites across Louisiana, Florida, New Jersey, and New York, we’re working together to advance new therapies in MASH/NAFLD, CNS, vaccines, ENT, respiratory, migraines, gastroenterology, pain, neurology, and general medicine trials.
Prolerity is Advancing Clinical Research
Prolerity Clinical Research is committed to establishing a world-class site network that conducts groundbreaking studies in diverse communities throughout our locations in the United States. Our dedicated team ensures the proper conduct of every clinical research study from patient recruitment to high-quality data collection to the very best in patient care.
Whether you’re a participant eager to contribute to groundbreaking studies or a researcher seeking a dynamic and professional environment, Prolerity is the hub for progress in clinical research. Explore our current studies, learn about our innovative approach, and be a part of a community dedicated to shaping the future of healthcare.
Why Choose
Prolerity?
National Excellence, Local Impact
Prolerity aims to be a national site network while making a meaningful impact in the local communities in which we reside across the United States. We will do this by bringing new treatment options to patients and focusing on serving the unique needs of diverse populations.
High-quality Data Collection
Accurate and reliable data is at the heart of every successful research study. Prolerity employs state-of-the-art data collection methods to ensure the integrity and quality of the information gathered.
Professional Research Expertise
Our experienced clinical and professional research staff brings a wealth of knowledge to every research study. With a commitment to patient safety and excellence, we strive to set the standard for clinical research quality.
Efficient Site Network
We’ve strategically established a site network (11 sites with more to come) to ensure clinical research studies are accessible and impactful across various regions. Prolerity is a highly regarded research site destination for pharmaceutical and biotech companies who depend on efficient, well-coordinated research sites who are capable of rapid patient recruitment and study startup to meet enrollment timelines.
Diverse Patient Populations
Every Prolerity clinic is intentionally situated in communities rich with diversity. Beyond providing access to the latest advances in treatments, these locations often serve as the primary source of medical care and education for many study participants. We are so pleased to be able to make a difference!
Deep Therapeutic Experience
Prolerity specializes in conducting novel and complex phase I – IV studies that contribute to the advancement of new treatments in fatty liver disease, Alzheimer’s disease, depression, migraine, asthma, Crohn’s disease, ulcerative colitis, IBS, weight loss, schizophrenia, diabetes, gastroparesis, sinus issues, heartburn, hearing loss and more.
“At Prolerity, our mission is to bring together the best and brightest in clinical research to execute the highest quality clinical trials without the protracted timelines. Reliability, momentum, and exemplary care for all our patients will always be the core values driving our research.”
Jeff Williams | CEO, Prolerity Clinical Research
Where excellence matters.